Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.

International journal of molecular sciences - 4 Dec 2021

Kang Minyong, Lee Hyunwoo, Byeon Sun-Ju, Kwon Ghee Young, Jeon Seong Soo

Abstract excerpt

Intraductal carcinoma of the prostate (IDC-P) is a rare and unique form of aggressive prostate carcinoma, which is characterized by an expansile proliferation of malignant prostatic epithelial cells within prostatic ducts or acini and the preservation of basal cell layers around the involved glands. The vast majority of IDC-P tumors result from adjacent high-grade invasive cancer via the retrograde spreading of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair
Share to Genomic Instability
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Prostatic Neoplasms

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 34884926
DOI: 10.3390/ijms222313125
PMCID: PMC8658449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.PMID 34884926Read ↗

Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?Semantic proximity Read ↗

Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateSemantic proximity Read ↗

Current Understanding and Management of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia ( PIN ) and intraductal carcinoma through retrograde glandular colonizationSemantic proximity Read ↗

Intraductal carcinoma of the prostate in the absence of high‐grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsSemantic proximity Read ↗

Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype.Semantic proximity Read ↗

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationSemantic proximity Read ↗

Is high-grade prostatic intraepithelial neoplasia (HGPIN) a reliable precursor for prostate carcinoma? Implications for clonal evolution and early detection strategies.Semantic proximity Read ↗

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterationsSemantic proximity Read ↗

Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.Semantic proximity Read ↗

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.Semantic proximity Read ↗

Clinical variability and molecular heterogeneity in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.